Table 3. Suggestions on when to adjudicate in future stroke trials.

Outcome	SI blind to treatment allocation when assessing outcome	SI not blind to treatment allocation when assessing outcome
Primary outcome: stroke or a composite including stroke	Adjudication is less important	Adjudication is more important
Primary outcome: functional outcome measured on the mRS	Adjudication is less important	Adjudication is more important
Subjective key safety or secondary outcome	Adjudication is less important	Adjudication is more important
Objective key safety or secondary outcome	Adjudication is not important	Adjudication is more important
Other outcome	Adjudication is not important	Adjudication is not important

SI: site investigator; mRS: modified Rankin Scale.